"MESM is recognized and valued by many of the world's largest pharmaceutical customers and contract research organizations, including a number of existing VWR customers who currently procure our clinical trial and biorepository services," said
Founded in 2007, MESM is headquartered in Chorley,
Financial details of this acquisition remain confidential.
VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is the leading global independent provider of product and service solutions to laboratory and production customers. With sales in excess of $4.5 billion in 2016, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers' productivity from research to production. VWR's differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 10,200 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.
For more information on VWR, please visit www.vwr.com.
Director, Corporate Communications
VP, Investor Relations
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vwr-acquires-mesm-ltd-300436430.html
News Provided by Acquire Media